Study genes in breast and prostate cancers in Brazil
Part of Cancer, Kidney & urinary, Skin clinical trials.
This study looks at tumor tissue and blood to map genetic features of breast and prostate cancers in Brazil. It helps understand cancer patterns in the public health system and may guide future testing and treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older
- If breast cancer: you must be Brazilian and have a confirmed breast tumor diagnosis
- If prostate cancer: you must be a man with confirmed prostate cancer
- Your cancer stage must match the study (breast stage II–III for HER2+; breast stage I–III for triple-negative; prostate stage IV)
- You must have tumor tissue available (paraffin-embedded) for genetic testing
- You must be able to provide a blood sample, and you must sign consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses whole genome sequencing, a test that reads the complete set of your DNA, to study breast cancer tissue. This may help doctors learn more about the disease and find better treatments.
This study looks at stored tumor samples to understand why some people respond much better or much worse than expected. The goal is to learn what the tumor’s genes might be telling doctors about response to treatment.
This study tests the genes of your cancer to learn more about advanced breast, lung, melanoma, or sarcoma tumors. It may help doctors find better ways to treat these cancers in the future.
This study looks at the genes in your cancer to find a treatment that might work better for you. It tests your tumor sample to match you with a drug that targets your cancer's specific weaknesses.
This trial uses genetic test results from your prostate cancer to guide treatment choices. It may help find therapies that better match the specific gene changes in your cancer.
This trial looks at different drug combinations given before surgery to shrink breast tumors. The goal is to find which treatments work best for different types of breast cancer, such as triple-negative, HER2-positive, or hormone-receptor-positive. If you are a woman scheduled for neoadjuvant therapy (treatment before surgery) and have not had previous cancer treatment, this study may be for you.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.